VRTX Net Receivables
Vertex Pharmaceuticals · Net Receivables
VRTX Net Receivables
Latest reported$2.05Bperiod ending
VRTX FY Net Receivables ($0.00 → $2.05B)
Annual net receivables
High-resolution chart · PNG
VRTX net receivables history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 2,052,800,000 | |
| 1,609,400,000 | |
| 1,563,400,000 | |
| 1,442,200,000 | |
| 1,136,800,000 | |
| 885,400,000 | |
| 633,518,000 | |
| 409,688,000 | |
| 385,992,000 | |
| 235,483,000 | |
| 188,520,000 | |
| 90,057,000 | |
| 93,476,000 | |
| 143,250,000 | |
| 183,135,000 | |
| 12,529,000 | |
| 9,601,000 | |
| 23,489,000 | |
| 31,320,000 | |
| 62,923,000 | |
| 20,595,000 | |
| 11,891,000 | |
| 7,324,000 | |
| 13,200,000 | |
| 20,265,000 | |
| 33,906,000 | |
| 5,956,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |